Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.
Friederike LämmerClaire DelbridgeSilvia WürstleFrauke NeffBernhard MeyerJürgen SchlegelKerstin A KesselThomas E SchmidDaniela SchillingStephanie Elisabeth CombsPublished in: PloS one (2019)
These data suggest that the intracellular Hsp70 expression might serve as a prognostic marker in patients with primary GBM.